The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dissection of primary prostate cancer to determine the clonal origin of synchronous lymph node metastasis.
 
Srinivas Nallandhighal
No Relationships to Disclose
 
Jeffrey J. Tosoian
Stock and Other Ownership Interests - LynxDx
 
Udit Singhal
No Relationships to Disclose
 
Razeen Karim
No Relationships to Disclose
 
Romain Mathieu
No Relationships to Disclose
 
Komal Plouffe
Employment - Strata Oncology
 
Nathalie Rioux-Leclercq
No Relationships to Disclose
 
Javed Siddiqui
Consulting or Advisory Role - Strata Oncology
 
Chia-Jen Liu
No Relationships to Disclose
 
Daniel H. Hovelson
Employment - Strata Oncology
Consulting or Advisory Role - TERUMO
Travel, Accommodations, Expenses - Thermo Fisher Scientific
 
Claudio Doglioni
No Relationships to Disclose
 
Todd Matthew Morgan
Consulting or Advisory Role - Myriad Genetics; TERUMO
Research Funding - GenomeDx (Inst); MDxHealth (Inst); Myriad Genetics (Inst)
 
Martin Susani
No Relationships to Disclose
 
Roberta Luciano Luciano
No Relationships to Disclose
 
Shahrokh F. Shariat
Stock and Other Ownership Interests - Seagen; Urogen pharma
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Cepheid; Dr. August Wolff GmbH & Co. KG Arzneimittel; Ferring; Ipsen; Janssen; MSD; Olympus; Pfizer; Pierre Fabre; Roche; Sanochemia; Sanofi; Urogen pharma
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Cepheid; Ferring; Ipsen; Janssen; Lilly; MSD; Olympus; Pfizer; Pierre Fabre; Ribon Therapeutics; Roche; Sanochemia; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Bristol-Myers Squibb; Cepheid; Ferring; Ipsen; Janssen; Lilly; MSD; Olympus; Pfizer; Pierre Fabre; Ribon Therapeutics; Roche; Sanochemia; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent US07759077; Patent US20030054419; Patent US20030235816; Patent US2003235816
 
Scott A. Tomlins
Employment - Strata Oncology
Leadership - Strata Oncology
Stock and Other Ownership Interests - Javelin Oncology; Strata Oncology
Consulting or Advisory Role - Astellas Medivation; Janssen; Strata Oncology
Research Funding - Astellas Medivation (Inst)
Patents, Royalties, Other Intellectual Property - I am a coauthor on a patent issued to the University of Michigan on ETS gene fusions in prostate cancer. The diagnostic field of use has been licensed to Hologic/Gen-Probe Inc., who has sublicensed some rights to Ventana Medical Systems/Roche.
Travel, Accommodations, Expenses - Strata Oncology
 
Alberto Briganti
Consulting or Advisory Role - Astellas Pharma; Ferring; Janssen-Cilag; MDxHealth; OPKO Health
Speakers' Bureau - Astellas Pharma
Research Funding - Merck Sharp & Dohme; Sandoz-Novartis
 
Ganesh S. Palapattu
Stock and Other Ownership Interests - NantWorks
Consulting or Advisory Role - Janssen Scientific Affairs
Research Funding - Minomic
Patents, Royalties, Other Intellectual Property - implantable nanotechnology for long term testosterone delivery functionalized fiducial marker for drug delivery
 
Aaron M. Udager
No Relationships to Disclose
 
Simpa Samuel Salami
No Relationships to Disclose